Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: The effect is manifested only at the restricted tumor-bearing stages

Cancer Research

Volumn 57, Issue 18, 1997, Pages 4036-4041

  Yang, Yi Fu ^a   Zou, Jian Ping ^a   Mu, Jie ^a   Wijesuriya, Rishani ^a   Ono, Shiro ^a   Walunas, Theresa ^b   Bluestone, Jeffrey ^b   Fujiwara, Hiromi ^a   Hamaoka, Toshiyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOLOGY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FIBROSARCOMA; MALE; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; FEMALE; FIBROSARCOMA; IMMUNITY, CELLULAR; IMMUNOCONJUGATES; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; OVARIAN NEOPLASMS; SPLEEN; T-LYMPHOCYTES; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0030853610     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Van den Eynde, B., Lethe, B., Van Pel, A., De Plaen, E., and Boon, T. The gene coding for a major tumor rejection antigen of tumor K815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med., 173: 1373-1384, 1991.
2. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
3. Fujiwara, H., and Hamaoka, T. Regulatory mechanisms of anti-timor T cell responses in the tumor-bearing mice. Immunol. Res., 14: 271-291, 1995.
4. Mueller, D. L., Jenkins, M. K., and Schwartz, R. H. Regulatory mechanisms of anti-tumor T cell responses in the tumor-bearing mice. Immunol. Res., 14: 271-291, 1995.
5. Mueller, D. L., Jenkins, M. K., and Schwartz, R. H. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol., 7: 445-480, 1989.
6. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., and Allison, J. P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (Lond.), 356: 607-609, 1992.
7. June, C. H., Bluestone, J. A., Nadler, L. M., and Thompson, C. B. The B7 and CD28 receptor families. Immunol. Today, 15: 321-331, 1994.
8. Linsley, P. S., and Ledbetter, J. A. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol., 11: 191-212, 1993.
9. Brunet, J. F., Denizot, F., Luciani, M. F., Roux-Dosseto, M., Suzan, M., Mattei, M. G., and Golstein, P. A new member of the immunoglobulin superfamily: CTLA-4. Nature (Lond.), 328: 267-270, 1987.
10. Harper, K., Balzano, C., Rouvier, E., Mattei, M. G., Luciani, M. F., and Golstein, P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, messages expression, gene structure, and chromosomal location. J. Immunol., 147: 1037-1044, 1991.
11. Freeman, G. J., Borriello, F., Hodes, R. J., Resier, H., Hathcock, K. S., Laszlo, G., McKnight, A. J., Kim, J., Du, L., Lombard, D. B., Gray, G. S., Nadler, L. M., and Sharpe, A. H. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science (Washington DC), 262: 907-909, 1993.
12. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., and Bluestone, J. A. CTLA-4 can function as a negative regulator of T cell activation. Immunity, 1: 405-413, 1994.
13. Krummel, M. F., and Allison, J. P. CD28 and CTLA-4 shave opposing effects on the response of T cells to stimulation. J. Exp. Med., 182: 459-465, 1995.
14. Leach, D. R., Krummel, M. F., and Allison, J. P. Enhancement of antitumor immunity by CTLA-4 blockade. Science (Washington DC), 271: 1734-1736, 1996.
15. Yoshida, T. O., Haraguchi, S., Miyamoto, H., and Matsuo, T. Recognition of RSV-induced tumor cells in syngeneic mice and semisyngeneic reciprocal hybrid mice. Gann Monogr. Cancer Res., 23: 201-212, 1979.
16. Hashimoto, M., Niwa, O., Nitta, Y., Takeichi, M., and Yokoro, K. Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn. J. Cancer Res., 80: 459-463, 1989.
17. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., and Bluestone, J. A. CTLA-4 can function as a negative regulator of T cell activation. Immunity, 1: 405-413, 1994.
18. Shimizu, J., Zou, J. P., Ikegame, K., Katagiri, T., Fujiwara, H., and Hamaoka, T. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts. J. Immunol., 146: 1708-1714, 1991.
19. + T cell activity. J. Immunol., 148: 648-655, 1992.
20. + T cell function. Jpn. J. Cancer Res., 84: 315-325, 1993.
21. Zou, J. P., Yamamoto, N., Fujii, T., Takenaka, H., Kobayashi, M., Herrmann, S. H., Wolf, S. F., Fujiwara, H., and Hamaoka, T. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells. Int. Immunol., 7: 1135-1145, 1995.
22. Mu, J., Zou, J. P., Yamamoto, N., Tsutsui, T., Tai, X. G., Kobayashi, M., Herrman, S., Fujiwara, H., and Hamaoka, T. Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Cancer Res., 55: 4404-4408, 1995.
23. Utsumi, K., Takai, Y., Tada, T., Ohzeki, S., Fujiwara, H., and Hamaoka, T. Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production. J. Immunol., 145: 397-403, 1990.
24. Tada, T., Ohzeki, S., Utsumi, K., Takiuchi, H., Muramatsu, M., Li, X. F., Shimizu, J., Fujiwara, H., and Hamaoka, T. Transforming growth factor-β-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J. Immunol., 146: 1077-1082, 1991.
25. Yamamoto, N., Zou, J. P., Li, X. F., Takenaka, H., Noda, S., Fujii, T., Ono, S., Kobayashi, Y., Mukaida, N., Matsushima, K., Fujiwara, H., and Hamaoka, T. Regulatory mechanisms for production of IFN-γ and TNF by antitumor T cells or macrophages in the tumor-bearing state. J. Immunol., 154: 2281-2290, 1995.